Augmentation of antipsychotics with glycine may ameliorate depressive and extrapyramidal symptoms in schizophrenic patients – a preliminary 10-week open-label study
Journal Title: Psychiatria Polska - Year 2013, Vol 47, Issue 4
Abstract
Aim. The objective of this study was to analyze the changes in depressive and extrapyramidal symptomatology during glycine augmentation of antipsychotic treatment in patients with schizophrenia. Materials and methods. Twenty-nine schizophrenic patients (ICD-10) with predominant negative symptoms in stable mental state participated in a 10-week open-label prospective study. Patients received stable doses of antipsychotic drugs for at least 3 months before glycine application. During the next 6 weeks patients received augmentation of antipsychotic treatment with glycine (up to 60 g per day). The first and last two weeks of observation were used to assess stability of mental state. Symptom severity was assessed using the Hamilton Depression Rating Scale (HDRS), the Positive and Negative Syndrome Scale (PANSS), and the Simpson-Angus Extrapyramidal Symptom Rating Scale (SAS) Results. In the studied group after 6 weeks of administration of glycine a significant improvement in depressive symptoms (reduced scores by 25.8% in HDRS, p <0.001) and reduced scoring in mood symptoms of PANSS were observed. In SAS a reduction of extrapyramidal symptoms’ severity (p <0.05) was also noted. Two weeks after the glycine augmentation the symptom severity in the HDRS, PANSS, and SAS remained at similar levels. Conclusions. Glycine augmentation of antipsychotic treatment may reduce the severity of depressive and extrapyramidal symptoms. Glycine use was safe and well tolerated.
Authors and Affiliations
Dominik Strzelecki, Paweł Kropiwnicki, Jolanta Rabe-Jabłońska
Keywords
Related Articles
- EP ID EP135949
- DOI -
- Views 99
- Downloads 0
Polish version of Comprehensive Assessment of At Risk Mental States (CAARMS) – the description of the method
The first psychotic episode is usually preceded by the decline in functioning as well as the occurrence of symptoms, which due to low intensity or short duration do not fulfil the criteria allowing for the recognition of...
Seasonality of suicide in Poland. Analysis of the Main Statistical Office data for the years 1999–2003
Aim. The presented suicide seasonality analysis based on the Main Statistical Office general Polish population data is the first to deal with this problem in our country. An answer was sought to two research questions: w...
Cognitive dysfunctions in bipolar disorders
The aim of this article is to present the current state of knowledge in the field of cognitive dysfunctions in bipolar disorders (BD). These dysfunctions are considered to be a result of brain activation disorders and oc...
Deep brain stimulation – the newest physical method of treatment of depression
The deep brain stimulation DBS is the newest physical method of the treatment of depressive disorders. When applying of this technique in neurological illnesses (e.g. Parkinson’s disease), mood changes were observed. In...
Fragile X syndrome – child’s and parent’s problem
Summary Fragile X syndrome is the most common familial form of mental retardation. The incidence is estimated to be 1 in 4000 male births. The disease is caused by amplification of trinucleotide repeats CGG in the fir...